How to fortify the immunity of HIV patients
March 6, 2010 by admin · Leave a Comment
Contact: Sophie Langlois
sophie.langlois@umontreal.ca
514-773-0104
University of Montreal Read more
HIV vaccine strategy expands immune responses
March 2, 2010 by admin · Leave a Comment
Contact: James E. Rickman
jamesr@lanl.gov
505-665-9203
DOE/Los Alamos National Laboratory Read more
Pneumococcal vaccine offers protection to HIV-infected African adults in clinical trial
March 2, 2010 by admin · Leave a Comment
Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust
A clinical trial of a vaccine against a major cause of pneumonia and meningitis has shown that it can prevent three out of four cases of re-infection in HIV-infected adults in Africa.
Gene-based stem cell therapy specifically removes cell receptor that attracts HIV
February 24, 2010 by admin · Leave a Comment
Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-794-2273
University of California - Los Angeles
UCLA AIDS Institute researchers successfully removed CCR5 a cell receptor to which HIV-1 binds for infection but which the human body does not need from human cells. Individuals who naturally lack the CCR5 receptor have been found to be essentially resistant to HIV.
Combined drug therapy to treat TB and HIV significantly improves survival
February 24, 2010 by admin · Leave a Comment
Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University’s Mailman School of Public Health
Initiating antiretroviral therapy (ART) during tuberculosis therapy significantly reduced mortality rates by 56 percent in a randomized clinical trial of 642 patients co-infected with HIV and tuberculosis. The study, which provides further impetus for the integration of TB and HIV services, lays to rest the controversy on whether co-infected patients should initiate ART during or after TB treatment. Findings are published in the February 25th issue of The New England Journal of Medicine.
Penn researchers present Phase II HIV gene therapy trial data at CROI 2010
February 17, 2010 by admin · Leave a Comment
Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine Read more
Scientists discover origin of HIV transmission among male partners
February 9, 2010 by admin · Leave a Comment
Contact: Debra Kain
ddkain@ucsd.edu
619-543-6163
University of California - San Diego
A team of scientists, led by a virologist from the University of California, San Diego’s Center for AID Research (CFAR), has discovered the origin of strains of human immunodeficiency virus (HIV) among men who have sex with men. The study, which may be important in developing prevention strategies for HIV, will appear in Science Translational Medicine on February 10, 2010.
Researchers reveal 3-D structure of bullet-shaped virus with potential to fight cancer, HIV
February 7, 2010 by admin · Leave a Comment
Contact: Jennifer Marcus
jmarcus@cnsi.ucla.edu
310-267-4839
University of California - Los Angeles Read more
Scientists find two compounds that lay the foundation for a new class of AIDS drug
February 2, 2010 by admin · Leave a Comment
Contact: Keith McKeown
kmckeown@scripps.edu
858-784-8134
Scripps Research Institute Read more
HIV researchers solve key puzzle after 20 years of trying
January 30, 2010 by admin · Leave a Comment
Contact: Laura Gallagher
l.gallagher@imperial.ac.uk
44-020-759-48432
Imperial College London
Researchers have made a breakthrough in HIV research that had eluded scientists for over 20 years, potentially leading to better treatments for HIV, in a study published today in the journal Nature.
